…
Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Sector: Healthcare Industry: Diagnostics & Research
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| ID1 Identifai Genetics Limited |
-0.02 4.55% |
0.42 | - | - | - | - |
| SHL Sonic Healthcare Ltd |
0.09 0.45% |
19.92 | 16.16 | 17.21 | 0.90 | 1.15 |
| IDX Integral Diagnostics Ltd |
- -% |
1.70 | 28.83 | 15.24 | 0.82 | 0.97 |
| ACL Australian Clinical Labs Ltd |
0.01 0.30% |
3.33 | 26.67 | 16.84 | 0.81 | 3.95 |
| HLS Healius Ltd |
0.01 2.86% |
0.54 | - | 29.24 | 0.26 | 2.08 |
Identifai Genetics Limited provides prenatal genetic screening through the application of genome-wide sequencing and artificial intelligence in Israel, the United States, Hong Kong, China, and Australia. The company's product, Windrose, is a first-trimester non-invasive prenatal test that provides cfDNA-based fetal risk assessment for more than 280 clinically actionable genes, all from a single blood draw and without requiring a partner sample. The company was founded in 2021 and is based in Subiaco, Australia.
| Name | Title | Year Born |
|---|---|---|
| Mr. Eyal Miller | Chief Executive Officer | NA |
| Oren Tadmor | Head of Product & Co-founder | NA |
| Gilad Magnazi | Chief Operating Officer | NA |
| Prof. Noam Shomron Ph.D. | C.S.O | NA |
| Mr. Sebastian Andre | Company Secretary | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.